Abstract:Policy Points Workers' compensation agencies have instituted opioid review policies to reduce unsafe prescribing. Providers reported more limited and cautious prescribing than in the past; both patients and providers reported collaborative pain‐management relationships and satisfactory pain control for patients. Despite the fears articulated by pharmaceutical companies and patient advocates, opioid review programs have not generally resulted in unmanaged pain or reduced function in patients, anger or resistance from patients or providers, or damage to patient–provider relationships or clinical autonomy. Other insurance providers with broad physician networks may want to consider similar quality‐improvement efforts to support safe opioid prescribing. Context Unsafe prescribing practices have been among the central causes of improper reception of opioids, unsafe use, and overdose in the United States. Workers' compensation agencies in Washington and Ohio have implemented opioid review programs (ORPs)—a form of quality improvement based on utilization review—to curb unsafe prescribing. Evidence suggests that such regulations indeed reduce unsafe prescribing, but pharmaceutical companies and patient advocates have raised concerns about negative impacts that could also result. This study explores whether three core sets of problems have actually come to pass: (1) unmanaged pain or reduced function among patients, (2) anger or resistance to ORPs from patients or providers, and (3) damage to patient–provider relationships or clinical autonomy. Methods In‐depth semistructured interviews were conducted with 48 patients (21 from Washington, 27 from Ohio) and 32 providers (18 from Washington, 14 from Ohio) who were purposively sampled to represent a range of injury and practice types. Thematic coding was conducted with codebooks developed using both inductive and deductive approaches. Findings The consequences of opioid regulations have been generally positive: providers report more limited prescribing and a focus on multimodal pain control; patients report satisfactory pain control and recovery alongside collaborative relationships with providers. Participants attribute these patterns to a broad environment of opioid caution; they do not generally perceive workers' compensation policies as distinctly impactful. Both patients and providers comment frequently on the difficult aspects of interacting with workers' compensation agencies; effects of these range from simple inconvenience to delays in care, unmanaged pain, and reduced potential for physical recovery. Conclusions In general, the three types of feared negative impacts have not come to pass for either patients or providers. Although interacting with workers' compensation agencies involves difficulties typical of interacting with other insurers, opioid controls seem to have generally positive effects and are generally perceived of favorably.

Association Between Pre‐Injury Opioid Use and Opioid Use Patterns After a Work Injury

Associations between psychosocial factors and long‐term opioid use among injured workers receiving early opioids

Impact of workplace injury on opioid dependence, abuse, illicit use and overdose: a 36-month retrospective study of insurance claims

Opioid-related mortality after occupational injury in Washington State: accounting for preinjury opioid use

Opioid Prescribing Trends Among Workers' Compensation Patients Undergoing Foot and Ankle Surgery

Short‐acting opioid prescriptions and Workers' Compensation using the National Ambulatory Medical Care Survey

Preoperative opioid use and postoperative return to work following spinal surgery in workers’ compensation settings: A systematic review and meta-analysis

Opioid utilization after orthopaedic trauma hospitalization among Medicaid-insured adults

Post‐injury use of opioid analgesics in patients with traumatic injury: A registry‐based study

Risk of opioid-related harms by occupation within a large cohort of formerly injured workers in Ontario, Canada: findings from the Occupational Disease Surveillance System

Trends in the Use of Epidural Steroid Injections to Treat Back Pain Before Spine Surgery

A Prospective Evaluation of Patient-Reported Opioid Utilization after Nonoperative Treatment of Fractures and Dislocations

The Association Between Employment in Coal Mining and History of Injury, Current Pain, and Prescription Opioid Use

Persistent Opioid Use Following Pediatric Nonfatal Firearm Injury

Impacts of State‐Level Opioid Review Programs on Injured Workers and Their Health Care Providers: A Qualitative Study in Washington and Ohio

Factors influencing pain medication and opioid use in patients with musculoskeletal injuries: a retrospective insurance claims database study

Opioid Risk Tool, in-hospital opioid exposure, and opioid demand predict pain outcomes following traumatic injury

Prolonged Opioid Use and Associated Factors After Open Reduction and Internal Fixation of Tibial Shaft Fractures

Predicting at-risk opioid use three months after ed visit for trauma: Results from the AURORA study

Association of peri‐operative prescription of non‐steroidal anti‐inflammatory drugs with continued prescription of opioids after total knee arthroplasty: a retrospective claims‐based cohort study

The Association of Preoperative Opioid Use with Post-Discharge Outcomes